|
Interprotein
Corporation NEW
http://www.interprotein.com/
Interprotein
is engaged in developing small molecule
pharmaceuticals based on its novel in silico
drug design capability that explores small
molecule functions to target protein-protein
interactions. Several programs are currently
being developed in pre-clinical phase. The
company is also developing a series of compounds
targeting a new molecular function that a team
at Osaka University
discovered.
CellGentech,
Inc.
http://www.cellgentech.com/
CellGentech is a
biopharmaceutical company developing novel
gene-based therapeutics, which use
patent-protected technology incorporating
cultured adipocytes for ex vivo
gene therapy. The companyfs development
pipeline includes novel gene therapy products for
enzyme deficiency diseases and basal
insulin supplementation for diabetes. The company is also
developing a transdermal
product of a biopharmaceutical for pressure-ulcer
treatment.
RT Solutions,
Inc.
RT Solutions is engaged in
providing medical
services and technologies on an advanced
radiation oncology therapy in non medical insurance
basis. The company targets unmet medical needs
in radiation oncology, by which it provides
not only innovative technologies such as focal
radiation and 4D radiation, but also
involves in education of
radiation physists and technologists to maintain the best level of
medical services.
Anaeropharma
Science Inc.
http://www.anaeropharma.co.jp/
Anaeropharma
Science is a cancer drug development
company based on the unique drug delivery
technique using anaerobic bacteria such as the
genus Bifidobacterium. The company is
primarily focused on the tumor specific
enzyme/pro-drug therapy by using the genetically
engineered Bifidobacterium longum
.
APS was founded by three of Professors of
Shinshu University.
Periodoc
Inc.
http://www.periodock.co.jp/
Periodoc is a
molecular diagnostics and therapeutics
development venture, founded by two
gynecologists and one pathologist of Tokyo
Medical School, focused on womenfs diseases
such as endometriosis and dysmenorrhea. The
company is initiating its novel clinical
diagnostics at the molecular level, which allows
a drug discovery for every stage of diseases and
every individual.
NalaPro
Technologies, Inc.
http://www.nalapro.com/
NalaPro Technologies is a
bio-informatics development venture focused on
the biotech/medical text-mining technique,
founded by the team of two professors of Tokyo
University and a spinout of one of the largest
Japanese electronics companies. The company is
developing the search engines with the precise
machine dictionaries dedicated to the
biotech/medical fields, that enables
research/medical professionals to integrate
necessary comprehensive text information of
genomes, proteins, compounds and diseases from
the public and commercial
databases.
| 
